Type 1 Diabetes

Type 1 diabetes is an autoimmune disease characterized by the destruction of pancreatic beta cells, leading to an absolute deficiency of insulin secretion. Traditional medicine considers this condition to require lifelong dependence on insulin injections. There are approximately 9 million people globally living with Type 1 diabetes. Traditional treatment incurs annual costs exceeding RMB 10,000, often with suboptimal patient outcomes and difficulty in controlling the risk of complications.

Type 1 Diabetes ≠ Lifelong Insulin Dependence

Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital in China announced a breakthrough achievement: Since June 2024, they have successfully helped 24 patients with Type 1 diabetes discontinue insulin use and achieve functional cure through Holistic Integrative Medicine (HIM) – an optimized treatment protocol combining Chinese and Western medicine. The longest duration off insulin has reached 14 months. This breakthrough brings new hope for the global treatment of Type 1 diabetes and signifies significant progress in treating autoimmune diseases with an integrated approach.

(Patient from Hebei, China, recovered and was discharged on February 26, 2025)

Breakthrough Therapy: Precision Intervention under the HIM Model

The HIM model adopted by Professor An Chiying's team integrates holistic Traditional Chinese Medicine, orthomolecular medicine, functional medicine, lifestyle medicine, and precision tele-digital healthcare from endocrinology specialists. Focusing on immune blockade and metabolic balance, it has successfully achieved the restoration of pancreatic islet function and the cessation of insulin.

The core of this treatment plan lies in multidisciplinary collaboration, including:

· Precision Diagnosis: Utilizing mass spectrometry platforms to accurately identify the immunological etiology of Type 1 diabetes for targeted causal treatment.

· Immune Regulation: Modulating abnormal immune responses through molecular nutrition and Chinese herbal medicine to reduce the autoimmune attack on islet cells.

· Metabolic Repair: Employing acupuncture, Chinese herbal medicine, and nutritional interventions to improve the body's microenvironment and promote the recovery of islet function.

· Precision Monitoring: Using artificial intelligence to dynamically analyze patient blood glucose and immune markers, allowing for personalized adjustment of treatment strategies.

Patients typically require only a 3 to 5-day hospital stay before discharge.

（Professor An Chiying conducts a ward round for Type 1 Diabetes grade III at Shenzhen Hengsheng Hospital）

Clinical Data: 24 Patients Successfully Discontinued Insulin

During a two-year clinical observation, the team intervened with 70 patients diagnosed with Type 1 diabetes. Among them, 24 patients (34%) have completely discontinued insulin use. These patients maintain stable blood glucose levels (HbA1c < 7%), and C-peptide tests show significant recovery of islet function. Currently, these patients require only dietary management and regular follow-ups, with no dependence on exogenous insulin.

Professor An Chiying emphasized: "Functional cure refers to the partial recovery of islet function to a level sufficient for normal metabolic needs, achieved through immune blockade, intestinal mucosal repair, and gut microbiota reconstruction. Patients diagnosed early, with a C-peptide level higher than 0.5 ng/ml, have the potential to discontinue insulin; those with insufficient islet function can also significantly reduce their insulin dosage after achieving stable blood glucose levels."

Academician Evaluation: Pioneering a New Treatment Paradigm

Academician Fan Daiming, a member of the Chinese Academy of Engineering and a pioneer of Integrative Medicine in China, commented: "The results achieved by the Chinese team challenge the traditional concept that Type 1 diabetes requires lifelong medication. The synergistic effects of Integrative Medicine deserve attention from the global medical community, opening a new clinical treatment paradigm for Type 1 diabetes."

Why Choose Shenzhen Hengsheng Hospital?

· Breakthrough Treatment Technology: The Chronic Disease Integrative Medicine Center / Diabetes Naturopathy Center at Shenzhen Hengsheng Hospital innovatively applies the HIM health management protocol, integrating the essence of Chinese and Western medicine, and is committed to achieving functional cure for Type 1 diabetes.

· Authoritative Expert Team: The medical team led by Professor An Chiying, working in a multidisciplinary model, possesses extensive clinical experience and research capabilities, enabling them to provide patients with individualized and precise treatment plans.

· Comprehensive Management and Support: Combining tele-digital healthcare and AI monitoring enables dynamic adjustment during treatment and long-term follow-up, supporting patients' steady recovery and alleviating both economic and health burdens.

Contact Us
Chronic Disease Integrative Medicine Center / Diabetes Naturopathy Center
Shenzhen Hengsheng Hospital
Parent Company: Shanghai Fosun Group – Shenzhen Hengsheng Hospital